{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:35:51Z","timestamp":1793385351083,"version":"4.5.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:00:00Z","timestamp":1735084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Urothelial carcinoma in situ (CIS) with early papillary formation is terminology sometimes used to suggest incipient high-grade papillary urothelial carcinoma (PUC) but may lead to confusion between true CIS and lateral flat spread of PUC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>It remains unclear how pathologists and urologists interpret this scenario, so a survey was circulated to 68 pathologists (group 1 = 28 academic genitourinary pathologists; group 2 = 17 pathologists with a self-reported genitourinary focus; group 3 = 23 pathologists self-reported as not genitourinary specialists) and 32 urologists.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Regarding atypical urothelial lesions that appear mainly flat but contain possible papillae, group 3 was more likely to label this as CIS compared with groups 1 and 2 (35% for group 3 vs 13% for groups 1 and 2), while groups 1 and 2 more often adopted another descriptive diagnosis, such as \u201cCIS with early papillary features\u201d (38% for groups 1 and 2 vs 13% for group 3). Among all 3 groups, group 1 was most likely to diagnose concomitant CIS and PUC in the same specimen but in different tissue fragments (58%). Pagetoid spread was reported to favor CIS predominantly by group 1 (61%). Urologists felt that the term lateral spread\/shoulder was unclear (75%) and preferred early PUC (44%) or PUC with early growth (44%). Half (53%) of urologists felt that reporting CIS instead of lateral spread of PUC would change management.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Documentation of flat lesions lacks consensus among pathologists and may benefit from standardized terminology. Moreover, the distinction between CIS and early or lateral spread of PUC is not always clear to urologists and can influence disease management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqae167","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T16:29:33Z","timestamp":1735144173000},"page":"629-640","source":"Crossref","is-referenced-by-count":5,"title":["Urothelial carcinoma in situ with \u201cearly papillary formation\u201d vs \u201clateral spread\/shoulder lesion\u201d of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations"],"prefix":"10.1093","volume":"163","author":[{"given":"Ankur R","family":"Sangoi","sequence":"first","affiliation":[{"name":"Department of Pathology, Stanford University Medical Center , Stanford, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shahabi","sequence":"additional","affiliation":[{"name":"Chesapeake Urology , Beltsville, MD ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Sui (Sunny)","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Deebajah","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine A","family":"Barletta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladell P","family":"Paner","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Chicago School of Medicine , Chicago, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-4607","authenticated-orcid":false,"given":"Steven C","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology, Virginia Commonwealth University School of Medicine , Richmond, VA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Grignon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine , Indianapolis, IN ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comp\u00e9rat","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B","family":"Amin","sequence":"additional","affiliation":[{"name":"LabCorp Western Division , Oregon City, OR ,","place":["United States"]},{"name":"Departments of Urology and Pathology and Laboratory Medicine, USC Keck School of Medicine , Los Angeles, CA ,","place":["United States"]},{"name":"Departments of Urology and Pathology and Laboratory Medicine, University of Tennessee Health Science Center , Memphis, TN ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Maclean","sequence":"additional","affiliation":[{"name":"Douglass Hanly Moir Pathology , Macquarie Park ,","place":["Australia"]},{"name":"Franklin AI , Sydney ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajal B","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A","family":"Iczkowski","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, Davis , Davis , CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warick","family":"Delprado","sequence":"additional","affiliation":[{"name":"Douglass Hanly Moir Pathology , Macquarie Park ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Brown University School of Medicine , Providence, RI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chen","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Taipei Veterans General Hospital , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K","family":"McKenney","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Y","family":"Ro","sequence":"additional","affiliation":[{"name":"Department of Pathology, Houston Methodist Hospital , Houston, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Khani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medicine , New York, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[{"name":"Molecular Medicine and Cell Therapy Foundation, c\/o Polytechnic University of the Marche Region , Ancona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medicine , New York, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Al-Ahmadie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center , New York, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I","family":"Epstein","sequence":"additional","affiliation":[{"name":"IMP Pathology , Garden City, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[{"name":"Department of Pathology, Alberta Precision Laboratories and University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tretiakova","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Washington School of Medicine , Seattle, WA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital , Houston, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheen","family":"Alanee","sequence":"additional","affiliation":[{"name":"Detroit Medical Center and Michigan State University , Detroit, MI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Weight","sequence":"additional","affiliation":[{"name":"Glickman Urologic and Kidney Institute, Cleveland Clinic Foundation , Cleveland, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Akgul","sequence":"additional","affiliation":[{"name":"Albany Medical Center , Albany, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-1460","authenticated-orcid":false,"given":"Sean R","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,25]]},"reference":[{"key":"2025042102214308700_CIT0001","volume-title":"Urinary and Male Genital Tumours, WHO Classification of Tumours","year":"2022","edition":"5"},{"key":"2025042102214308700_CIT0002","volume-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Bladder Cancer. Version 5.","author":"National Comprehensive Cancer Network","year":"2024"},{"issue":"2","key":"2025042102214308700_CIT0003","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.01.005","article-title":"Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art","volume":"76","author":"Williamson","year":"2010","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"2025042102214308700_CIT0004","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0022-5347(17)68193-X","article-title":"Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy","volume":"68","author":"Melicow","year":"1952","journal-title":"J Urol."},{"issue":"4","key":"2025042102214308700_CIT0005","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0022-5347(17)68279-X","article-title":"Intra-urothelial cancer: carcinoma in situ, Bowen\u2019s disease of the urinary system: discussion of thirty cases","volume":"68","author":"Melicow","year":"1952","journal-title":"J Urol."},{"issue":"4-5","key":"2025042102214308700_CIT0006","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/s1078-1439(99)00020-4","article-title":"Updated concepts and treatment of carcinoma in situ","volume":"4","author":"Lamm","year":"1998","journal-title":"Urol Oncol."},{"issue":"5","key":"2025042102214308700_CIT0007","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/PAP.0000000000000239","article-title":"Urothelial carcinoma in situ (CIS): new insights","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv Anat Pathol."},{"issue":"1","key":"2025042102214308700_CIT0008","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol."},{"issue":"5","key":"2025042102214308700_CIT0009","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2014.10.040","article-title":"Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review","volume":"67","author":"Casey","year":"2015","journal-title":"Eur Urol."},{"issue":"6","key":"2025042102214308700_CIT0010","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1756287215599694","article-title":"Management of carcinoma in situ of the bladder: best practice and recent developments","volume":"7","author":"Tang","year":"2015","journal-title":"Ther Adv Urol"},{"issue":"4","key":"2025042102214308700_CIT0011","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-Muscle-Invasive Bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol."},{"key":"2025042102214308700_CIT0012","author":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","year":"2016","journal-title":"American Urological Association"},{"issue":"1","key":"2025042102214308700_CIT0013","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.juro.2010.03.032","article-title":"Clinical outcomes of primary bladder carcinoma in situ in a contemporary series","volume":"184","author":"Chade","year":"2010","journal-title":"J Urol."},{"issue":"1","key":"2025042102214308700_CIT0014","doi-asserted-by":"publisher","first-page":"48","DOI":"10.6004\/jnccn.2009.0004","article-title":"Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis","volume":"7","author":"Nese","year":"2009","journal-title":"J Natl Compr Canc Netw."},{"issue":"11","key":"2025042102214308700_CIT0015","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","article-title":"Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification","volume":"64","author":"Dyrskj\u00f8t","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"2025042102214308700_CIT0016","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/PAP.0000000000000308","article-title":"The Genitourinary Pathology Society update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach to lesions with mixed and early patterns of neoplasia","volume":"28","author":"Amin","year":"2021","journal-title":"Adv Anat Pathol."},{"key":"2025042102214308700_CIT0017","first-page":"81","article-title":"Infiltrating urothelial carcinoma","volume-title":"WHO Classification of Tumours of the Urinary System and Male Genital Tract","author":"Grignon","year":"2016","edition":"4"},{"issue":"10","key":"2025042102214308700_CIT0018","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41379-022-01087-7","article-title":"Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice","volume":"35","author":"Paner","year":"2022","journal-title":"Mod Pathol."},{"issue":"9","key":"2025042102214308700_CIT0019","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s41379-022-01062-2","article-title":"p53 null phenotype is a \u201cpositive result\u201d in urothelial carcinoma in situ","volume":"35","author":"Sangoi","year":"2022","journal-title":"Mod Pathol."},{"issue":"8","key":"2025042102214308700_CIT0020","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol."},{"issue":"8","key":"2025042102214308700_CIT0021","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"2025042102214308700_CIT0022","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pathol.2020.10.001","article-title":"Urothelial carcinoma in situ: diagnostic update","volume":"53","author":"McKenney","year":"2021","journal-title":"Pathology."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/4\/629\/61273429\/aqae167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/4\/629\/61273429\/aqae167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T06:21:57Z","timestamp":1745216517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/163\/4\/629\/7932421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,25]]},"published-print":{"date-parts":[[2025,4,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqae167","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,12,25]]}}}